Global Vancomycin-Resistant Enterococcus faecium Infections Therapeutics Pipeline Report 2016 - 18 Companies & Their Drug Profile Activity - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Vancomycin-Resistant Enterococcus faecium Infections - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Vancomycin-Resistant Enterococcus faecium Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Vancomycin-Resistant Enterococcus faecium Infections and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Vancomycin-Resistant Enterococcus faecium Infections Overview
  3. Therapeutics Development
  4. Pipeline Products for Vancomycin-Resistant Enterococcus faecium Infections - Overview
  5. Pipeline Products for Vancomycin-Resistant Enterococcus faecium Infections - Comparative Analysis
  6. Vancomycin-Resistant Enterococcus faecium Infections - Therapeutics under Development by Companies
  7. Vancomycin-Resistant Enterococcus faecium Infections - Therapeutics under Investigation by Universities/Institutes
  8. Vancomycin-Resistant Enterococcus faecium Infections Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Vancomycin-Resistant Enterococcus faecium Infections - Products under Development by Companies
  13. Vancomycin-Resistant Enterococcus faecium Infections - Products under Investigation by Universities/Institutes
  14. Vancomycin-Resistant Enterococcus faecium Infections - Companies Involved in Therapeutics Development
  • Alchemia Limited
  • Alvogen Korea Co., Ltd.
  • Aphios Corporation
  • Cellceutix Corporation
  • Helix BioMedix, Inc.
  • Hsiri Therapeutics, LLC
  • LegoChem Biosciences, Inc
  • Lytix Biopharma AS
  • MGB Biopharma Limited
  • MicuRx Pharmaceuticals, Inc.
  • Nanotherapeutics, Inc.
  • NovaBay Pharmaceuticals, Inc.
  • NovoBiotic Pharmaceuticals, LLC
  • Oragenics, Inc.
  • Sealife PHARMA GMBH
  • Sentinella Pharmaceuticals, Inc.
  • TAXIS Pharmaceuticals, Inc.
  • Wockhardt Limited

For more information visit http://www.researchandmarkets.com/research/fzqvt9/vancomycinresista

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases Drugs, Infectious Diseases Drugs, Antibiotics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases Drugs, Infectious Diseases Drugs, Antibiotics